115450.KQ
HLB Therapeutics Co.,Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 2,095.00
+0.96%Margins
Gross margin
6.3%
EBITDA margin
-11.0%
EBIT margin
-13.8%
Net margin
-25.1%
FCF margin
-9.0%
-11.3%
Return on equity
-7.4%
Return on assets
-4.8%
Return on invested capital
0.29x
Asset turnover
-KRW 1.2B
Cash from operations
KRW 156
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026